Ticker Details
Liquidia Technologies, Inc.
IPO Date:	July 23, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.92B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.34 | 3.37%
Avg Daily Range (30 D):	$1.28 | 3.28%
Avg Daily Range (90 D):	$1.03 | 3.14%

Institutional Daily Volume
Avg Daily Volume:	.74M
Avg Daily Volume (30 D):	1.99M
Avg Daily Volume (90 D):	1.78M

Trade Size
Avg Trade Size (Sh.):	98
Avg Trade Size (Sh.) (30 D):	66
Avg Trade Size (Sh.) (90 D):	66

Institutional Trades
Total Institutional Trades:	1,044
Avg Institutional Trade:	$2.08M
Avg Institutional Trade (30 D):	$2.44M
Avg Institutional Trade (90 D):	$2.66M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.6M
Avg Closing Trade (30 D):	$4.76M
Avg Closing Trade (90 D):	$4.74M
Avg Closing Volume:	161.97K

News

Sep 29, 2025 @ 12:30 PM Liquidia to Present Clinical Data from ASCENT Tria... Source: Globe Newswire

Aug 14, 2025 @ 5:00 PM Pulmonary Hypertension associated with Interstitia... Source: Delveinsight

May 23, 2025 @ 6:28 PM U.S. FDA Approves Liquidia’s YUTREPIAâ„Â... Source: Liquidia Corporation

May 12, 2025 @ 10:00 AM Liquidia Corporation Provides Update on Litigation... Source: N/A

May 2, 2025 @ 9:28 PM District Court Dismisses Dispute Filed by United T... Source: Liquidia Corporation

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-1.47	$-.04	$-.49
Diluted EPS	$-1.47	$-.04	$-.49
Revenue	$69.22M	$54.34M	$8.84M
Gross Profit
Net Income / Loss	$-124.09M	$-3.53M	$-41.58M
Operating Income / Loss	$-107.27M	$1.77M	$-37.51M
Cost of Revenue
Net Cash Flow	$-43.37M	$-15.93M	$7.17M
PE Ratio